HBK INVESTMENTS L P
Q2 2021 13F-HR Holdings
Net value change ($000)
+5,261,182
(31.0%)
New positions
161
Sold out positions
188
Turnover %
67.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| PRA Health Sciences, Inc. | 524,782 | NEW |
| SPY | 352,185 | 1025.4% |
| AMC | 49,491 | 6921.8% |
| META | 21,445 | 288.0% |
| DNA | 14,940 | NEW |
| Fortress Value Acquisition Corp. IV | 14,715 | NEW |
| Lead Edge Growth Opportunities, Ltd | 12,297 | NEW |
| Gores Guggenheim, Inc. | 12,206 | NEW |
| Heliogen, Inc. | 11,839 | NEW |
| APP | 11,276 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Talend S.A. | -24,183 | -100.0% |
| DNA | -15,180 | -100.0% |
| Fortress Value Acquisition Corp. IV | -14,850 | -100.0% |
| ZD | -12,952 | -100.0% |
| Gores Guggenheim, Inc. | -12,413 | -100.0% |
| ALIT | -11,702 | -77.7% |
| ORGN | -10,318 | -100.0% |
| Gores Technology Partners II, Inc. | -9,979 | -100.0% |
| Lead Edge Growth Opportunities, Ltd | -9,970 | -100.0% |
| BPGC Acquisition Corp. | -9,960 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
17,953,724
(80.7% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|